Tonix Pharmaceuticals Holding Corp.
TNXP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $75 | $2,362 | $23,926 | $1,613,965 |
| - Cash | $99 | $25 | $120 | $179 |
| + Debt | $8 | $10 | $1 | $1 |
| Enterprise Value | -$16 | $2,347 | $23,806 | $1,613,788 |
| Revenue | $10 | $8 | $0 | $0 |
| % Growth | 29.9% | – | – | – |
| Gross Profit | $2 | $3 | $0 | $0 |
| % Margin | 23.1% | 39% | – | – |
| EBITDA | -$74 | -$114 | -$111 | -$92 |
| % Margin | -736.3% | -1,468.7% | – | – |
| Net Income | -$130 | -$117 | -$110 | -$92 |
| % Margin | -1,288.3% | -1,501.8% | – | – |
| EPS Diluted | -176.6 | -6,368.84 | -811.68 | -163,968 |
| % Growth | 97.2% | -684.6% | 99.5% | – |
| Operating Cash Flow | -$61 | -$102 | -$98 | -$76 |
| Capital Expenditures | -$0 | -$8 | -$48 | -$35 |
| Free Cash Flow | -$61 | -$110 | -$146 | -$111 |